Smoking prevalence and attributable disease burden in 195 countries and territories, 1990–2015: a systematic analysis from the Global Burden of Disease Study 2015Marissa B Reitsma, Solomon Abrha Damtew, Nancy Fullman et al.|The Lancet|2017Cited by 2.1k
Review article: managing the adverse events caused by anti‐TNF therapy in inflammatory bowel diseaseUday N. Shivaji, Neeraj Bhala, C Sharratt et al.|Alimentary Pharmacology & Therapeutics|2019Cited by 155
Measuring progress on NCDs: one goal and five targetsRobert Beaglehole, K. Srinath Reddy, Ruth Bonita et al.|The Lancet|2012Cited by 107
Changing patterns in the epidemiology and outcomes of inflammatory bowel disease in the United Kingdom: 2000‐2018Dominic King, Nigel Trudgill, Tom Thomas et al.|Alimentary Pharmacology & Therapeutics|2020Cited by 91